Inhibitor Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Vasisht Niraj | — | Award / Grant | 50,000 | — | — | — | Apr 1, 2025 |
| Yanez Michelle | — | Award / Grant | 50,000 | — | — | 896,271 | Apr 1, 2025 |
| SEARS SAMUEL P JR | — | Award / Grant | 50,000 | — | — | 1,279,543 | Apr 1, 2025 |
| OSMAN RONALD E | — | Award / Grant | 50,000 | — | — | 23,554,985 | Apr 1, 2025 |
| Jerman Michael Allen | — | Award / Grant | 50,000 | — | — | 80,411 | Apr 1, 2025 |
| MCNULTY JAMES A | Chief Financial Officer | Gift | 1,000,000 | — | — | 1,946,135 | Dec 2, 2024 |
| Yanez Michelle | — | Gift | 250,000 | — | — | 1,146,271 | Dec 2, 2024 |
| SEARS SAMUEL P JR | — | Award / Grant | 50,000 | — | — | 1,129,543 | Apr 1, 2024 |
| Ronald E Osman Irrevocable Trust III | — | Award / Grant | 50,000 | — | — | 23,564,985 | Apr 1, 2024 |
| Jerman Michael Allen | — | Award / Grant | 50,000 | — | — | 80,411 | Apr 1, 2024 |
| Yanez Michelle | — | Award / Grant | 50,000 | — | — | 896,271 | Apr 1, 2024 |
| Ronald E Osman Irrevocable Trust III | — | Award / Grant | 25,000 | — | — | 23,514,985 | Aug 11, 2023 |
| MCNULTY JAMES A | See Remarks | Other | 398,135 | — | — | 946,135 | May 5, 2023 |
| Yanez Michelle | — | Other | 796,271 | — | — | 800,673 | May 5, 2023 |
| Mayne Pharma International Pty Ltd | — | Other | 2,240,488 | — | — | 204,083,227 | Jan 15, 2021 |
| Mayne Pharma International Pty Ltd | — | Other | 3,189,688 | — | — | 201,842,739 | Jul 15, 2020 |
| Watson W. Mark | — | Purchase | 500 | $0.06 | $30 | 1,054,100 | Dec 12, 2019 |
| Hasara Garrison J. | CFO and Treasurer | Purchase | 13,500 | $0.07 | $945 | 3,972,544 | Dec 2, 2019 |
| Mayne Pharma International Pty Ltd | — | Other | 362,121 | — | — | 198,653,051 | Jan 15, 2019 |
| Martin Robert Daniel | — | Award / Grant | 60,000 | $0.08 | $4,800 | 116,000 | Dec 20, 2018 |
| MAGRAB E. BRENDAN | — | Award / Grant | 65,000 | $0.08 | $5,200 | 65,000 | Dec 20, 2018 |
| Hasara Garrison J. | CFO and Treasurer | Sale | 100,000 | $0.27 | $27,000 | 3,959,044 | Aug 30, 2018 |
| Mayne Pharma Ventures Pty Ltd | — | Other | 184,798 | — | — | 198,290,930 | Jul 15, 2018 |
| Cross Stefan | — | Purchase | 600,000 | $162,660.00 | $97,596,000,000 | — | Dec 19, 2017 |
| Mayne Pharma International Pty Ltd | — | Purchase | 600,000 | $162,660.00 | $97,596,000,000 | 198,106,132 | Dec 19, 2017 |
| HedgePath, LLC | — | Sale | 2,500,000 | — | — | 79,627,069 | Jun 30, 2017 |
| Watson W. Mark | — | Tax Withholding | 79,200 | $0.34 | $26,928 | 553,600 | Mar 8, 2017 |
| Hasara Garrison J. | CFO and Treasurer | Tax Withholding | 1,470,478 | $0.34 | $499,963 | 2,029,522 | Mar 8, 2017 |
| VIRCA NICHOLAS J | President and CEO | Tax Withholding | 6,314,219 | $0.34 | $2,146,834 | 8,727,519 | Mar 8, 2017 |
| Cross Stefan | — | Option Exercise | 300,000 | — | — | 600,000 | Mar 8, 2017 |
| Ono Richard Dana | — | Option Exercise | 300,000 | — | — | 300,000 | Mar 8, 2017 |
| Mayne Pharma International Pty Ltd | — | X | 4,750,569 | — | — | 192,645,799 | Nov 15, 2016 |
| Mayne Pharma International Pty Ltd | — | X | 33,333,000 | — | — | 187,895,230 | Nov 4, 2016 |
| HedgePath, LLC | — | Sale | 2,560,000 | — | — | 82,127,069 | Jun 15, 2016 |
| ODONNELL FRANCIS E JR | Executive Chairman | Purchase | 2,560,000 | — | — | 16,560,000 | Jun 15, 2016 |
| ODONNELL FRANCIS E JR | Executive Chairman | Sale | 2,560,000 | — | — | 11,440,000 | Jun 15, 2016 |
| ODONNELL FRANCIS E JR | Executive Chairman | Other | 6,000,000 | — | — | 14,000,000 | Jun 6, 2016 |
| Mayne Pharma Ventures Pty Ltd | — | Award / Grant | 27,885,000 | — | — | 149,062,230 | May 25, 2016 |
| ODONNELL FRANCIS E JR | Executive Chairman | Purchase | 20,000,000 | — | — | 20,000,000 | Sep 10, 2015 |
| Mayne Pharma International Pty Ltd | — | Award / Grant | 33,333,333 | — | — | 121,177,230 | May 15, 2015 |
| Watson W. Mark | — | Purchase | 10,000 | $0.13 | $1,300 | 10,000 | Sep 8, 2014 |
| HedgePath, LLC | — | Sale | 20,000,000 | — | — | 84,687,069 | Aug 14, 2014 |
| HedgePath, LLC | — | Award / Grant | 2,530,227 | — | — | 2,530,227 | Jun 24, 2014 |
| ODONNELL FRANCIS E JR | Executive Chairman | Other | 141,693 | — | — | 141,693 | Jun 24, 2014 |
| FREER RICHARD J | Chief Executive Officer | Other | 2,846,715 | $0.05 | $142,336 | 7,485,141 | Apr 12, 2013 |
| SEARS SAMUEL P JR | — | Other | 372,263 | $0.05 | $18,613 | 1,016,096 | Apr 12, 2013 |
| FREER RICHARD J | Chief Executive Officer | Other | 2,025,000 | $0.02 | $40,500 | 4,638,426 | Aug 22, 2012 |
| D'Sylva Paul | — | Sale | 19,100 | $0.50 | $9,550 | 271,216 | Jan 19, 2010 |
| D'Sylva Paul | — | Purchase | 12,000 | $0.40 | $4,800 | 290,316 | May 29, 2009 |
| D'Sylva Paul | — | Purchase | 510 | $0.38 | $194 | 278,316 | May 14, 2009 |